1. Home
  2. Health Information
  3. Pharmaceutical Services
  4. Epoetin Lamda
Print this page Reduce font size Increase font size

Epoetin Lamda

Highly Specialised Drugs Program Declaration Form*

nsw health logo

 

 Patient’s Name:   ____________________________________
 Medical Record Number:   ____________________________________
 Medicare Number:     ____________________________________

                

 

I certify that the above patient meets the Pharmaceutical Benefits Advisory Committee’s criteria for funding under Section 100 of the National Health Act, 1953.

 

Criteria

Treatment of anaemia requiring transfusion, defined as a haemoglobin level of less than 100 g per L, where intrinsic renal disease, as assessed by a nephrologist, is the primary cause of the anaemia.

 

 

 

Specialist Prescriber

 

 Signature:  ____________________________________
 Name:  ____________________________________
 Date:  ____________________________________

 

 

 

*To be completed by the specialist initiating drug treatment, and retained by the hospital Pharmacy Department.

 

December 2010

Print this page Reduce font size Increase font size

This web page is managed and authorised by Pharmaceutical Services of Clinical Safety, Quality and Governance of the NSW Department of Health. Last updated: 6 December, 2010